Navigation Links
Commonly used 3-drug regimen for idiopathic pulmonary fibrosis found harmful
Date:10/21/2011

The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic pulmonary fibrosis (IPF) for safety concerns. The trial found that people with IPF receiving a currently used triple-drug therapy consisting of prednisone, azathioprine, and N-acetylcysteine (NAC) had worse outcomes than those who received placebos, or inactive substances.

"These findings underscore why treatments must be evaluated in a rigorous manner," said Susan B. Shurin, M.D., acting director of the NHLBI. "This combination therapy is widely used in patients with IPF, but has not previously been studied in direct comparison to a placebo for all three drugs."

The interim results from this study showed that compared to placebo, those assigned to triple therapy had greater mortality (11 percent versus 1 percent), more hospitalizations (29 percent versus 8 percent), and more serious adverse events (31 percent versus 9 percent) and also had no difference in lung function test changes. Participants randomly assigned to the triple- therapy arm also remained on their assigned treatment at a much lower rate (78 percent adherence versus 98 percent adherence).

"Anyone on some combination of these medications with questions or concerns should consult with their health care provider and not simply stop taking the drugs," said Ganesh Raghu, M.D., professor of medicine at the University of Washington, Seattle and a co-chair of this IPF study. "It is important to realize that these results definitively apply only to patients with well-defined IPF and not to people taking a combination of these drugs for other lung diseases or conditions."

The other two study arms, or intervention groups, of this IPF trial comparing NAC alone to placebo alone will continue. In stopping this part of the trial, the NHLBI accepted the
'/>"/>

Contact: NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung and Blood Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Commonly used supplement may improve recovery from spinal cord injuries
2. Commonly used defibrillators raise risk of problems
3. Study shows PRP, commonly used technique to improve healing, doesnt work in rotator cuff surgery
4. Hepatitis C patients likely to falter in adherence to treatment regimen over time, Penn study shows
5. Integrating medication regimens into daily routines can improve adherence
6. Best post-transplant drug regimen identified for patients with new kidneys
7. Asian lung cancer patient survival exceeds Caucasians on multiple regimens
8. Early success of anti-HIV preventive oral drug regimen is promising, but questions remain
9. 6-month drug regimen cuts HIV risk for breastfeeding infants, NIH study finds
10. Bleeding Risk With Plavix-Aspirin Regimen May Be Serious
11. Studies Tout Alternative HIV Regimens for Women, Babies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... A newly launched program is available for the ... and pre-diabetes. As opposed to traditional pharmaceutical methods, Reverse ... sufferers to reverse their disease without the use of ... the U.S. diabetes industry made $250 billion from the ... use of insulin and other glucose-controlling medications that act ...
(Date:3/3/2015)... The physicians at Diet Doc have formulated ... that is being recommended by fast weight loss specialists ... that help people lose weight while improving the mood. ... thought to possess innovative solutions to the complexities of ... directed at targeting specific strategic points for fast ...
(Date:3/3/2015)... T-System Inc. today announced the ... FABC as the company’s chief nursing officer along with ... care. , “Today’s patients are demanding more ... urgent care and freestanding emergency centers one of the ... T-System’s chief executive officer. “We have a strong ...
(Date:3/3/2015)... FL (PRWEB) March 03, 2015 The ... segment which covers some great ideas when planning an ... but with an environmentally friendly approach. The segment will ... determine a hotel or resort’s sustainability policy, request Earth-friendly ... will also remind viewers about how to save electricity ...
(Date:3/3/2015)... Farms, MI (PRWEB) March 03, 2015 The ... is being held at the Ford Conference Center, Dearborn, MI, ... Information Technology, Inc., is a featured speaker. He is ... Of Big Data.” , These designations were earned due ... world’s 1st commercially-available NoSQL DB, released over 10 years ...
Breaking Medicine News(10 mins):Health News:New Breakthrough In Diabetes Reaserch Show Scientifically Proven Way To Reverse Your Diabetes Naturally In 30 Short Days 2Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 2Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 3Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 4Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 3Health News:Forbes Living Segment on Planning an Eco-Vacation in the Works 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4
... any period of time after leaving the foster care ... than those with stable housing situations, according to a ... & Adolescent Medicine, one of the JAMA/Archives journals. Youth ... after leaving the foster care system appear to have ...
... 1 More than 125 leaders,from throughout the ... joined,together to support a multi-year, statewide campaign to ... campaign, launched by Nemours Health,and Prevention Services (NHPS), ... health professionals, parents, and other leaders to,improve the ...
... 1 In response to the,Supreme Court,s refusal to ... contraception from its health care coverage, Judie Brown,president of ... exercise of legislating via judicial fiat has reached new ... in defense of,religious organizations which do not want to ...
... Mylan Laboratories Inc.,(NYSE: MYL ) today announced the ... effective October 22, 2007. Mr. Byala joins Mylan,from Pfizer ... planning in both New York and Dublin. Mr. Byala ... positions of increasing responsibility.,Prior to Pfizer, Mr. Byala was ...
... Medical, Inc.,(Nasdaq: NXTM ), the manufacturer of ... announced that the Company has completed its,acquisition of ... million shares of NxStage common stock. "I ... place to realize the,significant opportunities that we see ...
... WASHINGTON, Oct. 1 A visionary leader, ... high-level recognition,for her outstanding contributions to the ... Americas during the 27th Pan American Sanitary ... Leadership in,Inter-American Health is bestowed upon creative ...
Cached Medicine News:Health News:Poor health care access common among youth leaving foster system 2Health News:Poor health care access common among youth leaving foster system 3Health News:More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delaware's Kids the Healthiest in the Nation 2Health News:More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delaware's Kids the Healthiest in the Nation 3Health News:Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer 2Health News:NxStage Medical Completes Acquisition of Medisystems 2Health News:NxStage Medical Completes Acquisition of Medisystems 3Health News:Inter-American Leadership Award Bestowed Upon Chilean Chronic Disease Expert 2
(Date:3/2/2015)...  DURECT Corporation (Nasdaq: DRRX ) ... successful completion of a Phase 1 clinical trial ... is an endogenous, small-molecule, new chemical entity (NCE), ... such as nonalcoholic fatty liver disease (NAFLD) and ... such as acute kidney injury (AKI).        ...
(Date:3/2/2015)... 2015  Intrexon Corporation (NYSE: XON ... its fourth quarter and full year results for ... Developments: , Acquired ActoGeniX, a European clinical ... cellular therapeutics and other innovative products.  Its proprietary ... microbes ( Lactococcus lactis ) to generate biologically-contained ...
(Date:3/2/2015)... DIEGO, March 2, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... quarter and full year ended December 31, 2014. Financial highlights ... a net loss of $5.3 million, or $0.04 per share. ... loss of $22.0 million, or $0.19 per share, for the ... 2014 include revenues of $75.3 million and a net loss ...
Breaking Medicine Technology:DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 3Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 4Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 6Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 7Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 8Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 9Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 10Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 11Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 12Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 13Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 14Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 15Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 16Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 17Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 18Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 19Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 20Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 21Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 22Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 23Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 24Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 2Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 3Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 4Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 5Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 6Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 7Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 8Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 9
... N.J., April 7, 2011 C3i, the global leader ... industry and Oracle Gold Partner, announced today the opening ... operations center, located in the northern city of Dalian, ... including Chinese, Korean and Japanese, to sponsors and clinical ...
... 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ... CSKI ), a leading fully integrated ... ("PRC"), today announced that the Company, jointly with ... production licenses for thirteen new medical products from ...
Cached Medicine Technology:C3i Opens Asia Language Center in Dalian, China 2China Sky One Medical Obtains Production Licenses for Thirteen New Medical Products 2China Sky One Medical Obtains Production Licenses for Thirteen New Medical Products 3
... leg bags are part of the ... line of leg bags, kits, and ... needs of our customers. These leg ... and constructed of 100% latex-free soft, ...
... are part of the Freedom Urinary ... leg bags, kits, and accessories designed ... our customers. These leg bags are ... of 100% latex-free soft, textured medical ...
... leg bags are part of the ... line of leg bags, kits, and ... needs of our customers. These leg ... and constructed of 100% latex-free soft, ...
The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict...
Medicine Products: